Using methods such as brain scans and symptom tracking, scientists are beginning to study whether a complex psychedelic brew known as ayahuasca can help rewire the brain's response to trauma.

No new PTSD drug approvals in the U.S. in nearly 25 years; large potential addressable market for SPC-15 worldwide SARASOTA, FL, July 07, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (SILO) (“Silo” or ...

Add Yahoo as a preferred source to see more of our stories on Google. The FDA recalled a drug prescribed by VA doctors to veterans suffering from post-traumatic stress disorder nightmares. A drug ...

MIAMI – The lack of progress in development of drugs to effectively treat posttraumatic stress disorder (PTSD) has become a "crisis" and has led to a significant shift in the US Department of Veterans ...

COLUMBUS, Ohio (WCMH) — Ohio lawmakers heard emotional testimony this week from several veterans, each describing how ...

SARASOTA, FL, May 14, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery ...

Explore innovative anxiety and PTSD treatments with Addex Therapeutics' groundbreaking research on mGlu7 modulators.

An experimental drug reverses PTSD-like symptoms in mice. The corresponding study was published in Signal Transduction and Targeted Therapy and may pave the way for a new treatment for PTSD. “This ...

(RTTNews) - Silo Pharma, Inc. (SILO) has announced a partnership with medical device company Resyca BV to conduct a drug-device study supporting the FDA IND submission for its lead asset SPC-15, an ...

Only two drugs are currently approved by the FDA for treating PTSD, both of which primarily target the depressive effects of the condition. In contrast, SPC-15’s differentiated method of action is ...